Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.

$279M

Market Cap • 12/26/2024

2014

(10 years)
Founded

2022

(2 years ago)
IPO

NASDAQ

Listing Exchange
Flag of US

Cambridge

Headquarters • Massachusetts